United States Liposomes Drug Delivery Market Report 2017

November 2017 | 107 pages | ID: U750A82EB79WEN
QYResearch

Abstracts

In this report, the United States Liposomes Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Liposomes Drug Delivery in these regions, from 2012 to 2022 (forecast).

United States Liposomes Drug Delivery market competition by top manufacturers/players, with Liposomes Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Johnson & Johnson
• Gilead Sciences
• Luye Pharma
• Sun Pharmaceutical
• Pacira
• Fudan-Zhangjiang
• Sigma-Tau Group
• Teva Pharmaceutical
• CSPC
• Novartis
• Crucell
• Celsion Corporation
• Kingond Pharm
• Shanghai New Asia
• Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Fungal Infection Therapy
• Cancer Therapy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Liposomes Drug Delivery Market Report 2017

1 LIPOSOMES DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Classification of Liposomes Drug Delivery by Product Category
  1.2.1 United States Liposomes Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Liposomes Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3
  1.2.4
1.3 United States Liposomes Drug Delivery Market by Application/End Users
  1.3.1 United States Liposomes Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Fungal Infection Therapy
  1.3.3 Cancer Therapy
1.4 United States Liposomes Drug Delivery Market by Region
  1.4.1 United States Liposomes Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Liposomes Drug Delivery Status and Prospect (2012-2022)
  1.4.3 Southwest Liposomes Drug Delivery Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Liposomes Drug Delivery Status and Prospect (2012-2022)
  1.4.5 New England Liposomes Drug Delivery Status and Prospect (2012-2022)
  1.4.6 The South Liposomes Drug Delivery Status and Prospect (2012-2022)
  1.4.7 The Midwest Liposomes Drug Delivery Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Liposomes Drug Delivery (2012-2022)
  1.5.1 United States Liposomes Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 United States Liposomes Drug Delivery Revenue and Growth Rate (2012-2022)

2 UNITED STATES LIPOSOMES DRUG DELIVERY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Liposomes Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Liposomes Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Liposomes Drug Delivery Average Price by Players/Suppliers (2012-2017)
2.4 United States Liposomes Drug Delivery Market Competitive Situation and Trends
  2.4.1 United States Liposomes Drug Delivery Market Concentration Rate
  2.4.2 United States Liposomes Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Liposomes Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIPOSOMES DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Liposomes Drug Delivery Sales and Market Share by Region (2012-2017)
3.2 United States Liposomes Drug Delivery Revenue and Market Share by Region (2012-2017)
3.3 United States Liposomes Drug Delivery Price by Region (2012-2017)

4 UNITED STATES LIPOSOMES DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Liposomes Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Liposomes Drug Delivery Revenue and Market Share by Type (2012-2017)
4.3 United States Liposomes Drug Delivery Price by Type (2012-2017)
4.4 United States Liposomes Drug Delivery Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LIPOSOMES DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Liposomes Drug Delivery Sales and Market Share by Application (2012-2017)
5.2 United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIPOSOMES DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Luye Pharma
  6.3.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
  6.4.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pacira
  6.5.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Fudan-Zhangjiang
  6.6.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sigma-Tau Group
  6.7.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical
  6.8.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 CSPC
  6.9.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.2 Liposomes Drug Delivery Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Crucell
6.12 Celsion Corporation
6.13 Kingond Pharm
6.14 Shanghai New Asia
6.15 Spectrum Pharmaceuticals

7 LIPOSOMES DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Liposomes Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liposomes Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liposomes Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liposomes Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIPOSOMES DRUG DELIVERY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Liposomes Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Liposomes Drug Delivery Sales Volume Forecast by Type (2017-2022)
11.3 United States Liposomes Drug Delivery Sales Volume Forecast by Application (2017-2022)
11.4 United States Liposomes Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Liposomes Drug Delivery
Figure United States Liposomes Drug Delivery Market Size (K Units) by Type (2012-2022)
Figure United States Liposomes Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Liposomes Drug Delivery Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Liposomes Drug Delivery by Application in 2016
Figure Fungal Infection Therapy Examples
Table Key Downstream Customer in Fungal Infection Therapy
Figure Cancer Therapy Examples
Table Key Downstream Customer in Cancer Therapy
Figure United States Liposomes Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure The West Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Sales (K Units) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Liposomes Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States Liposomes Drug Delivery Sales Share by Players/Suppliers
Figure United States Liposomes Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Liposomes Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Liposomes Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States Liposomes Drug Delivery Revenue Share by Players/Suppliers
Table United States Market Liposomes Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Liposomes Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Liposomes Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States Liposomes Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Liposomes Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Liposomes Drug Delivery Product Category
Table United States Liposomes Drug Delivery Sales (K Units) by Region (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Sales Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Region in 2016
Table United States Liposomes Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Revenue Market Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Revenue Market Share by Region in 2016
Table United States Liposomes Drug Delivery Price (USD/Unit) by Region (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) by Type (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Type (2012-2017)
Figure United States Liposomes Drug Delivery Sales Share by Type (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Type in 2016
Table United States Liposomes Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Liposomes Drug Delivery by Type (2012-2017)
Figure Revenue Market Share of Liposomes Drug Delivery by Type in 2016
Table United States Liposomes Drug Delivery Price (USD/Unit) by Types (2012-2017)
Figure United States Liposomes Drug Delivery Sales Growth Rate by Type (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) by Application (2012-2017)
Table United States Liposomes Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Application in 2016
Table United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Luye Pharma Basic Information List
Table Luye Pharma Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Pacira Basic Information List
Table Pacira Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pacira Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Pacira Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Pacira Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Fudan-Zhangjiang Basic Information List
Table Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Sigma-Tau Group Basic Information List
Table Sigma-Tau Group Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table CSPC Basic Information List
Table CSPC Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSPC Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure CSPC Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure CSPC Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Novartis Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Novartis Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Crucell Basic Information List
Table Celsion Corporation Basic Information List
Table Kingond Pharm Basic Information List
Table Shanghai New Asia Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liposomes Drug Delivery
Figure Manufacturing Process Analysis of Liposomes Drug Delivery
Figure Liposomes Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Liposomes Drug Delivery Major Players/Suppliers in 2016
Table Major Buyers of Liposomes Drug Delivery
Table Distributors/Traders List
Figure United States Liposomes Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Liposomes Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Liposomes Drug Delivery Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type in 2022
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application in 2022
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Liposomes Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources